Emcure Pharmaceuticals announced a royalty-free voluntary licensing agreement with Gilead Sciences Ireland UC, a subsidiary of the California-based Gilead Sciences, to manufacture and supply generic versions of lenacapavir, the antiretroviral...
Sapience Therapeutics, Inc., a biotechnology company in the clinical stage, has reported the enrollment of the initial patient in its phase 2 dose expansion study for ST316, the company's innovative antagonist of b-catenin. The study's phase 1...
Merck, also recognized as MSD in countries other than the United States and Canada, revealed the finalization of the acquisition of CN201 from Curon Biopharmaceutical (Curon), a new experimental bispecific antibody in clinical development for...
The Competition Commission of India (CCI) gave approval to Mankind Pharma's acquisition of Bharat Serums and Vaccines for Rs 13,630 crore. Mankind Pharma, a publicly traded company, is involved in creating, producing, and selling a wide variety of...
.jpg)
Sun Pharma announced that they have signed a worldwide licensing deal to market Philogen's specialty anti-cancer immunotherapy Fibromun (L19TNF) from Switzerland and Italy. bPhilogen is conducting registration trials for Fibromun to treat soft...
Regor Pharmaceuticals (USA), a branch of Regor Therapeutics Group, a biotech company in the clinical testing phase, has agreed to a deal where Genentech, part of the Roche Group, will buy a set of advanced CDK inhibitors from Regor to treat breast...
Venus Remedies Ltd, a leading pharmaceutical company, announced that it has obtained approvals to market two important oncology medications (carboplatin and bortezomib) in Morocco and the Philippines. "These approvals are pivotal in our...
Boston Scientific Corporation, a leading company in the field of global medical technology, stated that it has been granted approval by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan for the FARAPULSE Pulsed Field Ablation (PFA)...
Drug manufacturer Dr Reddy's Laboratories Ltd has invested $620 million into its wholly-owned branch, Dr Reddy’s Laboratories SA, Switzerland (DRL SA). This investment is consistent with the company's previous board-approved decision to invest up...
CSIR-Central Drug Research Institute (CDRI), an esteemed research institute in the field of biomedicine, has revealed a partnership with Blockchain For Impact (BFI) to participate in the BFI-BIOME Virtual Network Programme. This partnership will...
, CDSCO.jpg)
